VALERIE FUSCO: Open Payments
NPI 1457002495 · MELROSE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 6 payments from 5 companies in 2025. Trend: 2023 $267 · 2024 $44 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $198 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $109 |
| ABBVIE INC. | 1 | $107 |
| ACADIA Pharmaceuticals Inc | 1 | $101 |
Products named: REXULTI, AIRSUPRA, BLUJEPA, SKYRIZI, NUPLAZID.
Industry payments across MA — which companies pay providers there.
